Litigation Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Docket		Date Filed	2017-08-04
Court	District Court, D. Kansas	Date Terminated	2022-07-11
Cause	28:1407 Multi-District Litigation	Assigned To	Daniel Dale Crabtree
Jury Demand	Both	Referred To	Teresa James
Parties	ADAM KLEIN; AETNA INC.; ALENE MCDANIEL; ALL DEFENDANTS (FOR LEAD/LIAISON COUNSEL ONLY); ALL PLAINTIFFS (FOR LEAD/LIAISON COUNSEL ONLY); AMBER RAINEY; AMERIGROUP CORPORATION; AMIE VIALET DE MONTBEL; ANASTASIA JOHNSTON; ANGIE NORDSTRUM; ANNETTE SUTORIK; ANTHEM INSURANCE COMPANIES, INC.; ANTHEM, INC.; APRIL SUMNER; ARISSA PASCHALIDIS; BLUE CROSS BLUE SHIELD MASSACHUSETTS; BLUE HORIZON CROSS BLUE SHIELD OF NEW JERSEY; CAREFIRST, INC.; CARLY BOWERSOCK; CASSANDRA BREDEK; CASSANDRA COBB; CHANGE HEALTHCARE, INC.; CHRIS RIPPY; CHRISTINA JAMES; CHRISTINA KOLLMEYER; CONNIE STAFFORD; CONSUMER CLASS CASES PLAINTIFFS; COVENTRY HEALTH CARE; CURT PALMER; CVS HEALTH CORPORATION; DAVID H. SMITH; DENYA ANDERSON; DONNA ANNE DVORAK; DONNA WEMPLE; EILEEN MONTET; ELAN KLEIN; ELIZABETH HUELSMAN; ELIZABETH WILLIAMSON; EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING, SALES PRACTICES AND ANTITRUST LITIGATION; ERIN KORTE-LAMPARTER; EXPRESS SCRIPTS HOLDING COMPANY; EXPRESS SCRIPTS, INC.; FRANCIS MEYERS; HEATHER BRESCH; HEATHER DESTEFANO; HEATHER RULAND; HONORABLE MARGARET R. HINKLE (RET.); HUMANA PHARMACY SOLUTIONS, INC.; HUMANA, INC.; JAE JONES; JAMIE HERR; JENNIFER WALTON; JOHN DODGE; JOY SHEPARD; JUDICIAL PANEL ON MULTIDISTRICT LITIGATION; KAISER FOUNDATION HEALTH PLAN, INC.; KAISER FOUNDATION HOSPITALS; KALEO, INC.; KENNETH EVANS; KENNETH STEINHAUSER; KIMBERLY CORCORAN; KIMBERLY DOLLANDER; KING PHARMACEUTICALS, INC.; KING PHARMACEUTICALS, LLC; KPH HEALTHCARE SERVICES, INC.; LANDON IPSON; LAURA CHAPIN; LAUREN COALE; LEAH WEAVER; LEE SELTZER; LESLEY HUSTON; LINDA WAGNER; LINDSEY RIZZO; LISA VOGEL; LOCAL 282 WELFARE TRUST FUND; LORI COLLINS; LORRAINE WIGHT; MARIA GIURLAND; MARK KOVARIK; MEDIMPACT HEALTHCARE SYSTEMS, INC.; MEREDITH KRIMMEL; MERIDIAN MEDICAL TECHNOLOGIES, INC.; MICHAEL GILL; MIRIAM CLARKE; MYLAN N.V.; MYLAN PHARMACEUTICALS, INC.; MYLAN SPECIALTY, LP; MYLAN, INC.; NIKITIA MARSHALL; OPTUMRX, INC.; PFIZER, INC.; PLAINTIFFS' STEERING COMMITTEE; PRIME THERAPEUTICS, LLC; RACHEL FERNANDEZ; RAYMOND C. BUCHTA, III; ROBERT MONTOYA; ROSETTA SERRANO; SANOFI-AVENTIS US, LLC; SEGAL GROUP, INC.; SHANNON CLEMENTS; SONYA NORTH; STACEE SVITES; SUZANNE HARWOOD; TEIA AMELL; TEVA PHARMACEUTICAL USA, INC.; THOMAS HADLEY; TODD BEAULIEU; TRACI BRANNON; UNITEDHEALTH GROUP, INC.; VALERIE MOORE; VISHAL AGGARWAL; WILLIAM DELPRINCIPE
Patents	6,996,927; 7,449,012; 7,794,432; 8,048,035; 8,870,827; 8,961,968; 8,961,973; 8,980,931; 8,992,352; 9,603,943; 9,657,003
Attorneys	Ada Wang; Adam K. Levin; Adam Scott Tolin; Alison Elizabeth Chase; Amanda Klevorn; Angela (Angel) D. Mitchell; Archie Irwin Grubb , II; Arnold B. Calmann; Arthur L. Shingler , III; Arthur R. Miller; Ben Barnow; Benjamin Frederick Holt; Bradley Beall; Bradley Joseph Schlozman; Brendan Woodard; Brian C. Fries; Brian D. Penny; Brian Murphy; Brian O. O'Mara; Brian R. Richichi; Brigid Bone; Camille S. Bass; Carolyn Anne DeLone; Chad E. Blomberg; Charles A. Loughlin; Charles Jacob Gower; Charles T. Schimmel; Chenyuan Fu; Christopher D. Edelman; Christopher Holding; Christopher J. Cormier; Craig L. Briskin; Cristina R. Delise; Damien J. Marshall; Daniel C. Hedlund; Daniel E. Gustafson; Daniel Thomas Graham; David A. Perez; David E. Delorenzi; David F. Oliver; David M. Foster; Dennis Lienhardt , Jr.; Derek William Loeser; Devan Calleen Rittler-Patton; Devon Paul Allard; Diane P. Sullivan; Dimitrios Drivas; Donald A. Ecklund; Duane L. Loft; E. Powell Miller; Edward Thrasher; Elizabeth C. Pritzker; Emily Hughes; Eric Andrew Rivas; Eric D. Barton; Eric Fierro; Eric Shaun Hochstadt; Erich Paul Schork; Erin Marie James; Eugene Mikolajczyk; Felicia Craick; Gregory M. Bentz; Gretchen Freeman Cappio; Ian S. Millican; Isaac L. Diel; Ivan Navedo; J. Nick Badgerow; Jacob Benjamin Ebin; James Bringhurst Eubank; James E. Cecchi; James Moloney; Jason Scott Goldstein; Jeffrey N. Luthi; Jeffrey S. Soos; Jennifer B. Wieland; Jennifer Fountain Connolly; Jennifer Kan; Jennifer Varon; Jessica Arden Ettinger; Jiamie Chen; John A. Stratford; John Bagnall Webb; John Bredehoft; John Goerlich; John Robert Robertson; Jon Myer Talotta; Jonathan K. Levine; Joseph Adamson; Joseph Alm; Joseph C. Bourne; Joseph G. Sauder; Joseph M. Rebein; Justin Bernick; Kasie M. Braswell; Katherine Booth Wellington; Kathryn M. Ali; Kathryn Swisher; Kathryn Zecca; Keith O'Doherty; Kersten L. Holzhueter; Kimberly Rancour; Korey Nelson; Lauren Jacobson; Lea Bays; Lee Turner Friedman; Lisa Marie Madalone; Luna Ngan Barrington; Lydia Wright; Lynn Lincoln Sarko; Mahde Youssef Abdallah; Maissa Chouraki; Mark Palley; Mary Mifflin Drake; Matthew S. Tripolitsiotis; Maxwell Goins; Melissa Rutman; Michael David Gendall; Michael J. Prame; Michael W. Meredith; Mitchell E. Zamoff; Mitchell L. Herren; Nathaniel David White; Patrick Thomas Egan; Paul J. Geller; Peter D. St. Phillip , Jr.; Philip A. Sechler; Raj Gandesha; Ralph C. Mayrell; Randi Singer; Reagan E. Bradford; Rex A. Sharp; Robert Ashby Pate; Robert E. Boston; Robert Milne; Robert William Taylor; Rosemary Medellin Rivas; Roy T. Englert , Jr.; Ryan C. Hudson; Ryan McDevitt; Samuel Kadosh; Sandra J. Durkin; Sarah Humble; Sarah L. Segal; Scott B. Goodger; Scott Simmer; Sean Murray; Sharon S. Almonrode; Sheryn George; Silvia M. Medina; Spencer Cox; Stacy A. Burrows; Stephen J. Fearon , Jr.; Steve W. Berman; Steven N. Williams; Steven Rivera; Stuart A. Davidson; Sue Lin; Susan E. Foster; Tanya Korkhov; Taylor Foye; Thomas J. Hershewe; Thomas L. Boeder; Thomas P. Cartmell; Timothy Gordon Blood; Timothy Robert Herman; Tyler W. Hudson; Ursula A. Taylor; W. Daniel Miles , III; W. Greg Wright; W. Mark Lanier; Warren T. Burns; William D. Beil; William L. Kalas; Yehudah L. Buchweitz; Yuri Fuchs
Firms	Angela (Angel) D. Mitchell; Archie Irwin Grubb , II; Barnow and Associates PC; Baron & Budd, PC; Beasley Allen Crow Methvin Portis & Miles; Berkowitz Oliver LLP KCMO; Blood Hurst & O'Reardon, LLP; Blood Hurst and O'Reardon LLP; Boies, Schiller & Flexner LLP (Armonk); Boies, Schiller & Flexner LLP (DC); Boies, Schiller & Flexner, LLP - NY; Braswell Murphy, LLC; Burns Charest New Orleans; Burns Charest, LLP Dallas; Burns Charest, LLP Greenwood Village; CAD Law, LC; Carella, Byrne, Cecchi, Olstein, Brody & Agnello, PC; Cerner Corporation MO; Clerk of the MDL Panel; Cotchett Pitre and McCarthy; Daniel Thomas Graham; DLA Piper LLP (US); Dollar, Burns & Becker, LC; German May PC; Goldman, Scarlato & Penny, Pc; Goodwin Procter, LLP MA; Groom Law Group, Chartered; Hagens Berman Sobol Shapiro LLP Seattle; Hinkle Law Firm LLC East Wichita Office; Hogan Lovells US LLP; Hogan Lovells US LLP MN; Hogan Lovells US, LLP DC; Hogan Lovells US, LLP DC555; Hogan Lovells, US LLP-DC; Joseph Saveri Law Firm; Joseph Saveri Law Firm, Inc.; Kaufman & Canoles; Keller Rohrback, LLC Seattle; Keller Rohrback, LLP New York; Keller Rohrback, LLP-Phoenix; Keller Rohrback, LLP-Santa Barbara; Lathrop Gage, LLP Kansas City; Lathrop GPM, LLP Kansas City; Law Offices of George A. Barton, PC; Levi & Korsinsky, LLP; Lightfoot Franklin White; Lowey Dannenberg, Pc; Marion's Inn LLP; Mayer Brown LLP; McCune Wright Arevalo, LLP; Mehri & Skalet PLLC; Miller Law Firm Pc; Pearson Simon & Warshaw LLP; Perkins Coie LLP Seattle; Pritzker Levine LLP; Reed Smith; Rex a Sharp PA; Robbins Geller Rudman & Dowd LLP (San Diego); Robbins Geller Rudman & Dowd, LLP - Boca Raton; Robbins, Russell, Englert, Orseck, Untereiner & Sauber LLP; Robins Geller Rudman & Dowd LLP - FL; Robins Kaplan LLP; Sharp Barton, LLP; Sharp Barton, LLP Metcalf; Sharp Law; Sharp Law, LLP College Blvd.; Sharp McQueen PA OP; Shook, Hardy & Bacon LLP - KC/Grand; Spencer Fane LLP KC; Squitieri and Fearon LLP; Steven Rivera; Strategic Health Law; Susan E. Foster; The Lanier Law Firm; The Lanier Law Firm PC; The Lanier Law Firm, PC; The Miller Law Firm; Timothy Robert Herman; U.S. Department of Justice Civil Division; Wagstaff & Cartmell LLP; Waller, Lansden, Dortch & Davis, L.L.C.; Weil, Gotshal & Manges LLP - Dallas; Weil, Gotshal & Manges LLP (CA); Weil, Gotshal & Manges, LLP - New York; Weil, Gotshal & Manges, LLP - NJ; Wexler Wallace LLP; White & Case LLP (NY)
Link to Docket	External link to docket

Biologic Drugs cited in In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES.

Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-01-22	123	Response to Motion	subsidiaries, sued Teva for infringing U.S. Patent No. 7,449,012. The claim was amended in November…monopoly resulting from a drug patent; indeed, Defendants have patents only on one of many possible delivery… With their additional patents in place—one of which, U.S. Patent No. 7,794,432, having been sought…stressing that Mylan was adding yet another patent to the already-patented EpiPen device in order to “put in…Intelliject’s e-cue infringed the ‘432 patent, despite that the ‘432 patent was not obtained until September	External link to document
2019-08-22	1848	Memorandum in Support of Motion	EpiPen patents, U.S. Patent Nos. 7,449,012 (the “’012 Patent”) and 7,794,432 (the “’432 Patent”).2 Prior…opines on the validity of the ’432 patent, but fails to apply accepted patent validity legal principles. Indeed… history to conclude that “the patent claims of the ’432 patent [were] quite weak, … the ’432 patent after the KSR decision. Thus, the PTO agreed the invention was patentable even under… Analyzing Patent Validity Professor Torrance posits that the ’432 patent is “quite weak	External link to document
2020-02-27	2017	Memorandum & Order - Unsealed Copy	evidence that the ’432 Patent is unenforceable due to patent misuse?” Doc. 1837-8 at 3 (Pls.’ Statement… likely outcome of the underlying patent litigation.” Doc. 1848 at 8 n.10. Plaintiffs respond that Prof…litigation (a lawsuit related to the Teva patent litigation). Doc. 1837-8 at 3 (Pls.’ Statement of Contested…428 U.S. at 121); see also Celgene Corp. v. Peter, 931 F.3d 1342, 1356 (Fed. Cir. 2019) (recognizing that…the fact that it was not raised below.” Celegene, 931 F.3d at 1356 (citations omitted).	External link to document
2020-02-27	2018	Memorandum & Order - Unsealed Copy	pending resolution of the patent litigation King had filed. Doc. 1500 at 33. Six months later, the parties…Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 996 (8th Cir. 2016) (discussing criticism of the Third…Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 996 (8th Cir. 2016); and then citing Rikos v. Procter…provided by law”); Freeman v. Sorchych, 245 P.3d 927, 936 (Ariz. Ct. App. 2011) (listing one of the elements… Patent Infringement Lawsuits The Pfizer defendants own the patents protecting the	External link to document
2020-04-22	2059	Order on Motion for Leave to File	Nuvigil patent infringement Case 2:17-md-02785-DDC-TJJ Document 2059 Filed 04/22/20 Page 2 of 8 …compliance by filing a motion to compel (ECF No. 992). On October 5, 2018, the Court granted Class Plaintiffs…). 6 Pfeiffer v. Eagle Mfg. Co., 137 F.R.D. 352, 355 (D. Kan. 1991). 7 Deghand, 904 F. Supp. … allegation that the April 2012 settlement of patent infringement claims involving EpiPen… allegations that the April 2012 settlement of patent infringement claims involving EpiPen and Nuvigil	External link to document
2020-07-20	2170	Motion to Strike	U.S. Patent No. 8,048,035 (“’035 Patent”), was issued by the USPTO in November 2011. These …two additional EpiPen patents were awaiting approval by the U.S. Patent and Trademark Office …application for what would become U.S. Patent No. 8,870,827 (the “’827 Patent”) was made publicly available… ’827 Patent was issued by the USPTO in October 2014.186 Another EpiPen-related patent, U.S.… patents differ from prior patents held by Pfizer on EpiPen Auto-Injector and more specifically	External link to document
2021-05-24	2353	Exhibit List	re EpiCard 649 2008.11.11 US Pat 7,449,012 650 2009.01.01 Patent Case Mgmt Judicial Guide Excerpts…Presentation 665 2020.06.25 Patent Examining Manual - 2142 666 2020.06.25 Patent Examining Manual - 2145…Krauss Email to Clarke 356 UNDATED. Report on Patent Expiration and Counter- 357 UNDATED. Pfizer Presentation	External link to document